Correlation Between Cisco Systems and Tcr2 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cisco Systems and Tcr2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cisco Systems and Tcr2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cisco Systems and Tcr2 Therapeutics, you can compare the effects of market volatilities on Cisco Systems and Tcr2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cisco Systems with a short position of Tcr2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cisco Systems and Tcr2 Therapeutics.

Diversification Opportunities for Cisco Systems and Tcr2 Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Cisco and Tcr2 is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cisco Systems and Tcr2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tcr2 Therapeutics and Cisco Systems is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cisco Systems are associated (or correlated) with Tcr2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tcr2 Therapeutics has no effect on the direction of Cisco Systems i.e., Cisco Systems and Tcr2 Therapeutics go up and down completely randomly.

Pair Corralation between Cisco Systems and Tcr2 Therapeutics

If you would invest  5,881  in Cisco Systems on November 29, 2024 and sell it today you would earn a total of  527.00  from holding Cisco Systems or generate 8.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Cisco Systems  vs.  Tcr2 Therapeutics

 Performance 
       Timeline  
Cisco Systems 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cisco Systems are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Cisco Systems may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Tcr2 Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tcr2 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Tcr2 Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Cisco Systems and Tcr2 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cisco Systems and Tcr2 Therapeutics

The main advantage of trading using opposite Cisco Systems and Tcr2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cisco Systems position performs unexpectedly, Tcr2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tcr2 Therapeutics will offset losses from the drop in Tcr2 Therapeutics' long position.
The idea behind Cisco Systems and Tcr2 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios